Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8836 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8733 |
High Similarity |
NPD2534 |
Approved |
0.8733 |
High Similarity |
NPD2533 |
Approved |
0.8733 |
High Similarity |
NPD2532 |
Approved |
0.8701 |
High Similarity |
NPD1934 |
Approved |
0.8681 |
High Similarity |
NPD230 |
Phase 1 |
0.8654 |
High Similarity |
NPD3882 |
Suspended |
0.8526 |
High Similarity |
NPD2801 |
Approved |
0.85 |
High Similarity |
NPD6232 |
Discontinued |
0.8421 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8418 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8408 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8408 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8405 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8354 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8344 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8312 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8199 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD447 |
Suspended |
0.8171 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8155 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8133 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.8084 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8084 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8037 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8024 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD37 |
Approved |
0.7975 |
Intermediate Similarity |
NPD919 |
Approved |
0.7963 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7963 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7963 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.795 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7949 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7939 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7939 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7929 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7917 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7914 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7908 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7908 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7891 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7882 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7875 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7867 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7867 |
Intermediate Similarity |
NPD943 |
Approved |
0.7857 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD7228 |
Approved |
0.784 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7824 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7805 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7764 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7763 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7756 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD920 |
Approved |
0.7683 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7679 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.767 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7639 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7613 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.761 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7576 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7574 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7572 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7562 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7532 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7531 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2796 |
Approved |
0.75 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7484 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7471 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.747 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7453 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7448 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7438 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7425 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7417 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7341 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD3748 |
Approved |
0.731 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7285 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7273 |
Intermediate Similarity |
NPD411 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7248 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7248 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7247 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7239 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7209 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7205 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7186 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7186 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7173 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7167 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7128 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7124 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7119 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7112 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7102 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7095 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7083 |
Intermediate Similarity |
NPD228 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7072 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7039 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7025 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7005 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7 |
Intermediate Similarity |
NPD1006 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.6994 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6954 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6944 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6931 |
Remote Similarity |
NPD6776 |
Approved |
0.6931 |
Remote Similarity |
NPD6782 |
Approved |
0.6931 |
Remote Similarity |
NPD6780 |
Approved |
0.6931 |
Remote Similarity |
NPD6781 |
Approved |
0.6931 |
Remote Similarity |
NPD6777 |
Approved |
0.6931 |
Remote Similarity |
NPD6779 |
Approved |
0.6931 |
Remote Similarity |
NPD6778 |
Approved |
0.6914 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6914 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6914 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6914 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6911 |
Remote Similarity |
NPD7680 |
Approved |
0.6903 |
Remote Similarity |
NPD5647 |
Approved |
0.6902 |
Remote Similarity |
NPD4287 |
Approved |
0.6889 |
Remote Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD17 |
Approved |
0.6887 |
Remote Similarity |
NPD4626 |
Approved |
0.6887 |
Remote Similarity |
NPD1778 |
Approved |
0.6886 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD1283 |
Approved |
0.6875 |
Remote Similarity |
NPD6653 |
Approved |
0.6867 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6864 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6864 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD4288 |
Approved |
0.6852 |
Remote Similarity |
NPD5408 |
Approved |
0.6852 |
Remote Similarity |
NPD5405 |
Approved |
0.6852 |
Remote Similarity |
NPD5406 |
Approved |
0.6852 |
Remote Similarity |
NPD5404 |
Approved |
0.6846 |
Remote Similarity |
NPD405 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD1470 |
Approved |
0.6837
|
Remote Similarity |
NPD7783 |
Phase 2 |